Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1300 participants.
Also called NCT03423511
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,300 participants
- Registry
-
NCT03423511
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT03423511. Randomized; single masking; primary purpose treatment. Start 2021-12-31 (anticipated); primary completion 2023-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
- Acronym
- CRYSTAL
- Condition
- Coronary Artery Disease
- Intervention (Device)
- MiStent II coronary artery stent
- Intervention (Device)
- Xience or Promus coronary artery stents
- Lead sponsor
- Micell Technologies
- Collaborator
- Baim Institute for Clinical Research
- Collaborator
- North American Science Associates Inc.
- Collaborator
- Yale Cardiovascular Research Group
Record details
- Record id
cardio:ct-nct03423511- Content hash
91045d6807c88d6c1f9c14a004503aa4391c63cf315a4bb4efc33c26904439ab